Antiviral Research
Antiviral Research is a monthly peer-reviewed medical journal published by Elsevier covering research on all aspects of the development of drugs, vaccines and immunotherapies against viruses of animals and plants. The journal was established in 1981 and is an official publication of the International Society for Antiviral Research. Like other Elsevier publications, it has been accused of limiting access of publicly funded research to rest of the population, including other scientists and researchers. The editor-in-chief is Subhash Vasudevan.[1]
| Discipline | Antiviral drugs |
|---|---|
| Language | English |
| Edited by | Subhash Vasudevan |
| Publication details | |
| History | 1981–present |
| Publisher | |
| Frequency | Monthly |
| 10.103 (2021) | |
| Standard abbreviations ISO 4 (alt) · Bluebook (alt1 · alt2) NLM (alt) · MathSciNet (alt ) | |
| ISO 4 | Antivir. Res. |
| NLM | Antiviral Res |
| Indexing CODEN (alt · alt2) · JSTOR (alt) · LCCN (alt) MIAR · NLM (alt) · Scopus | |
| ISSN | 0166-3542 |
| OCLC no. | 610588089 |
| Links | |
| |
Abstracting and indexing
Antiviral Research is abstracted and indexed in Abstracts on Hygiene and Communicable Diseases, Elsevier BIOBASE, BIOSIS, Current Contents/Life Sciences, EMBASE, MEDLINE, PASCAL, FRANCIS, Science Citation Index, Scopus, and Tropical Diseases Bulletin. According to the Journal Citation Reports, the journal has a 2021 impact factor of 10.103.[2]
References
- ^ "Editorial board - Antiviral Research | ScienceDirect.com by Elsevier". www.sciencedirect.com.
- ^ "Antiviral Research". 2020 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2021.
External links
- Official website